My Cart

Human Claudin-9 / CLDN9 Full Length Protein, His,Twin-Strep Tag (Nanodisc)

Customer Reviews
Cat. No. / Size
Price
Qty
CL9-H5283-20ug
$1440.00
CL9-H5283-100ug
$5355.00
CL9-H5283-500ug
$12920.00
ETA of in-stock products:2 business days
Sub-Total$ 0

Product Details

  • Application

    1. Cell based assay (FACS or functional assay)
    2. Affinity testing (SPR / BLI)
    3. Screening (ELISA)
  • Synonyms

    CLDN9

  • Source

    Nanodisc Human Claudin-9 / CLDN9 Full Length Protein, His,Twin-Strep Tag (CL9-H5283) is expressed from Baculovirus-Insect cells. It contains AA Ala 2 - Val 217 (Accession # O95484-1).

    Predicted N-terminus: Met

    Request for sequence
  • Molecular Characterization

    Claudin-9 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the N-terminus, and a twin-strep tag at the C-terminus. The protein has a calculated MW of 27.9 kDa. The protein migrates as 22-25 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

    *The isotype control of empty/mock nanodisc (Cat. No. APO-H51H3) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Nanodisc membrane protein is wrapped by a synthetic phospholipid bilayer membrane structure, composed of membrane scaffold proteins (MSPs) and phospholipids.

    2. Synthesis Process

      Nanodisc reconstitution is a self-assembly process that starts from purified, detergent-solubilized membrane proteins and reconstitutes them into synthetic phospholipid bilayers stabilized by MSP1D1 membrane scaffold protein. This creates a stable, detergent-free environment that preserves native conformation and biological activity, with excellent homogeneity and full compatibility with cell-based assays such as FACS and binding assays in antibody discovery and screening (ELISA),etc.

  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    Supplied as 0.2 μm filtered solution in 20 mM HEPES, 150 mM NaCl, pH7.5 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Shipping and Storage

    This product is supplied and shipped on dry ice.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 3 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    Claudin-9 SDS-PAGE

    Human Claudin-9 / CLDN9 Full Length Protein, His,Twin-Strep Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • Bioactivity-ELISA

     Claudin-9 ELISA

    Immobilized Human Claudin-9 / CLDN9 Full Length Protein, His,Twin-Strep Tag (Cat. No. CL9-H5283) at 2 μg/mL (100 μL/well) can bind Anti-Claudin 9 Antibody with a linear range of 0.001-0.313 μg/mL (QC tested).

    Protocol
  • Bioactivity-SPR

     Claudin-9 SPR

    Anti-Claudin 9 Antibody captured on Protein G Chip can bind Human Claudin-9 / CLDN9 Full Length Protein, His,Twin-Strep Tag (Cat. No. CL9-H5283) with an affinity constant of 34.9 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol

Customer Reviews
Writing Reviews

Background

A tight junction protein with expression restricted to specific epithelia and the inner ear. It plays a role in paracellular ion permeability and auditory function. Its upregulation in certain cancers, including liver and pituitary tumors, marks it as an emerging target for antibody-based drug delivery.

Recent Advances

 
Drug Development Progress
  • English Name:

    Claudin-9

  • Category:

  • Approved Drugs:

    0 Details

  • Drugs in Clinical Trials:

    0 Details

  • Highest Development Stage:

    Preclinical

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background